108641-82-3
108641-82-3
Chemical Structure
DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8
- CAS No.: 108641-82-3
- Formula:C8H8D8N2O4S2
- Molecular Weight:276.40
IUPAC Name: 4,4'-disulfanediylbis(2-aminobutanoic-3,3,4,4-d4 acid)
InChIKey: ZTVZLYBCZNMWCF-SVYQBANQSA-N
SMILES: C(C(C(O)=O)N)(C(SSC(C(C(C(O)=O)N)([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H]
Biological Activity: DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8 is the deuterium labeled DL-Homocystine. DL-Homocystine is the double-bonded form of homocysteine and homocysteine is recognized as an important substance in the pathogenesis and pathophysiology of schizophrenia[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8 | 98.0% | DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8 is the deuterium labeled DL-Homocystine. DL-Homocystine is the double-bonded form of homocysteine and homocysteine is recognized as an important substance in the pathogenesis and pathophysiology of schizophrenia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Homocystine | 98.0% | DL-Homocystine is the double-bonded form of homocysteine and homocysteine is recognized as an important substance in the pathogenesis and pathophysiology of schizophrenia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Brown AS, et al. Homocysteine and schizophrenia: from prenatal to adult life. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Sep;29(7):1175-80. [Content Brief]
